Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo-Reference-Cited by-同舟云学术

Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo

Published:2023-04 Issue:4 Volume:103 Page:772-781
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Tuttle Katherine R.,Bosch-Traberg Heidrun,Cherney David Z.I.,Hadjadj Samy,Lawson Jack,Mosenzon Ofri,Rasmussen Søren,Bain Stephen C.

Publisher

Elsevier BV

Subject

Nephrology

Reference38 articles.

1. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease;Thomas;Nat Rev Nephrol,2016

2. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Sarwar;Lancet,2010

3. Cardiovascular complications of chronic kidney disease: pioneering studies;Drüeke;Kidney Int,2020

4. Diabetic kidney disease: challenges, progress, and possibilities;Alicic;Clin J Am Soc Nephrol,2017

5. Cardiovascular complications of diabetic kidney disease;Pálsson;Adv Chronic Kidney Dis,2014

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mind the gap in kidney care: translating what we know into what we do;Brazilian Journal of Nephrology;2024-09

2. Mind the gap in kidney care: Translating what we know into what we do;Nefrología;2024-09

3. Atenção às lacunas no cuidado renal: traduzindo o que sabemos em ações;Brazilian Journal of Nephrology;2024-09

4. Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial;Diabetes, Obesity and Metabolism;2024-08-27

5. Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study;Diabetes Therapy;2024-08-08